AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Centrosome-associated PIBF gene is overexpressed in highly proliferating cells.

Women's Health Weekly

| December 02, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 DEC 2 - (NewsRx.com & NewsRx.net) -- The progesterone-induced blocking factor (PIBF) gene is overexpressed in highly proliferating cells and also is associated with the centrosome, report Intercell AG researchers.

Based on these findings, they suggest further study to see if highly expressed PIBF in tumors is directly involved in tumorigenesis.

"PIBF was previously identified as a 34-kDa immunomodulatory molecule secreted by pregnancy lymphocytes and is thought to play a crucial role in preventing rejection of the embryo by the maternal immune response. Recent data suggested that PIBF protein was also expressed by the progesterone receptor (PR) positive MCF-7 breast tumor cell line. Therefore our study was designed to analyze the expression of PIBF in malignant cell lines and primary tumors both at the mRNA and protein levels," said M. Lachmann and colleagues, Intercell AG, Vienna, Austria.

"RNA expression analyses of several human cell lines with different tissue origin and paired human tumor/normal tissues, as well as of several PR+ and PR- breast tumors revealed that PIBF mRNA was overexpressed in highly proliferating cells independent of the presence of PR," the researchers said.

"In addition to the full-length PIBF mRNA encoding for a 90-kDa protein, several alternatively spliced species were detected, all resulting from perfect exon skipping. The most frequently identified splice variant is predicted to encode for an approximately 35-kDa protein. Immunofluorescence microscopy revealed a centrosomal localization for the ...

Related articles from newspapers, magazines, journals, and more
Intercell AG to Host Research & Development day in NYC.
Press release article from: Business Wire October 18, 2006 700+ words
VIENNA, Austria -- Intercell AG (VSE; ICLL) will host a Research & Development...event will be archived on the Intercell Web site. About Intercell AG Intercell AG is a biotechnology company focused on the research, development...
Intercell AG Announces First Subject Enrolled in a Phase II Trial for the...
Press release article from: PR Newswire May 28, 2009 700+ words
...GAITHERSBURG, Md., May 28 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced that...stated Thomas Lingelbach, COO of Intercell AG and CEO of Intercell USA. "The recent...immunization visits are desired. About Intercell AG Intercell AG is an innovative ...
Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III...
Press release article from: PR Newswire January 19, 2009 700+ words
...C., Jan. 19 /PRNewswire/ -- Intercell AG has retained Inclinix, Inc., to recruit...in April 2009. "We are pleased that Intercell AG has chosen Inclinix as their partner...adverse events were reported. About Intercell AG Intercell AG is a growing biotechnology...
Intercell AG Joins OTCQX.
Press release article from: PR Newswire August 10, 2009 700+ words
...counter (OTC) securities, today announced that Intercell AG (VSE: ICLL, OTCQX: INRLY), a leading Austrian...s headquarters are in Vienna, Austria. About Intercell AG Intercell AG is an innovative biotechnology company that develops...
Researchers at Intercell AG publish new data on immunization.
Newspaper article from: Vaccine Weekly November 18, 2009 700+ words
...wrote A. Fritzer and colleagues, Intercell AG (see also Immunization). The researchers...information, contact A.L. Meinke, Intercell AG, Campus Vienna Bioctr 3, A-1030...Infection, Streptococcal, Streptococcus, Intercell AG. This article was prepared by Vaccine...
Researchers' work from Intercell AG focuses on west nile virus.
Newspaper article from: Biotech Week July 15, 2009 700+ words
...wrote P. Schlick and colleagues, Intercell AG (see also West Nile Virus). The researchers...information, contact P. Schlick, Intercell AG, Campus Vienna Bioctr 3, A-1030...Fever, West Nile Virus, Zoonoses, Intercell AG. This article was prepared by Biotech...
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline...
Press release article from: PR Newswire May 13, 2008 700+ words
- Intercell AG ('Intercell') to acquire Iomai Corporation ('Iomai') in a fully...Austria and GAITHERSBURG, Md., May 12 /PRNewswire-FirstCall/ -- Intercell AG (VSE: ICLL) and Iomai Corporation announced today that they have...
Intercell AG-Company Report.
Press release article from: M2 Presswire January 24, 2009 700+ words
...PRESSWIRE-24 January 2009-www.companiesandmarkets.com: Intercell AG-Company Report(C)1994-2009 M2 COMMUNICATIONS LTD...24012009 -www.companiesandmarkets.com adds new report: Intercell AG-Company Report Private Company Reports provide up to date...
For more facts and information, see all results

Source: HighBeam Research, Centrosome-associated PIBF gene is overexpressed in highly...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA